1. Modeling and predicting optimal treatment scheduling between the antiangiogenic drug sunitinib and irinotecan in preclinical settings. (11th December 2015) Authors: Wilson, S; Tod, M; Ouerdani, A; Emde, A; Yarden, Y; Adda Berkane, A; Kassour, S; Wei, MX; Freyer, G; You, B; Grenier, E; Ribba, B Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 4:Number 12(2015:Dec.) Page Start: 720 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗